The antiviral drug resistance market was valued at US$ 2,572.26 million in 2018 and it is projected to reach US$ 4,573.24 million in 2027; it is expected to grow at a CAGR of 6.8% from 2019 to 2027.
Antiviral drug resistance refers to decreased susceptibility towards a drug which occurs due to changes in viral genotypes. During instances of antiviral resistance, the drugs have either lost their effectiveness or have been diminished against the virus to be targeted. Antiviral drug resistance is a rising concern among the immune-compromised patients. The growth of the global antiviral drug resistance market is attributed to the rise in the incidences of hepatitis diseases and increasing prevalence of HIV/AIDS. However, alternative approaches is the major factor hindering the market growth.
The global antiviral drug resistance market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.
Lucrative Regions for Global Antiviral Drug Resistance Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Rise in the Incidences of Hepatitis Diseases to Drive Global Antiviral Drug Resistance Market Growth
Viruses are the tinier germs that can cause several infectious diseases such as flu, common cold, and warts. Viruses can also cause severe illnesses, including smallpox, HIV/AIDS, and Ebola. Viruses reproduce inside cells and able to enter into any living, healthy cells and multiply and produce other viruses like themselves. Different viruses attack specific cells in the body such as liver, brain, skin, blood and also reproductive, respiratory, and gastrointestinal systems.
The prevalence of virus infections such as hepatitis has increased during recent years across the globe. Hepatitis causes liver damage and inflammation that can also damage other organs. It is a major global health problem that can cause chronic infection and also upsurge the higher risk of death from cirrhosis and liver cancer. Hepatitis can be categorized as hepatitis A, B, C, D, and E that spread through different causes. According to the WHO (World Health Organization), the prevalence of Hepatitis B is the highest in the African and Western Pacific Region, where 6.1% and 6.2% of the adult population is infected respectively.
Moreover, 0.7% of the population is infected in the Region of the Americas. According to the WHO, 257 million people were living with chronic hepatitis B infection, in 2015 that resulted in an estimated 887,000 deaths mostly from cirrhosis and hepatocellular carcinoma. As of 2016, 27 million (10.5%) people were aware of their infection, while 4.5 million (16.7%) of the people diagnosed were on treatment.
Product -Based Insights
In terms of product, the global antiviral drug resistance market is segmented into kits and reagents and instruments. In 2018, the kits and reagents segment held largest share of the market. Moreover, the same segment is estimated to grow at the fastest rate during the forecast period.
Global Antiviral Drug Resistance Market, by Product – 2018 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Disease Indication-Based Insights
Based on disease indication, the global antiviral drug resistance market is segmented into HIV, hepatitis and Cytomegalovirus (CMV). The HIV segment held the largest market share in 2018. Also, the same segment is estimated to grow at the fastest rate during the forecast period.
Technology-Based Insights
In terms of technology, the global antiviral drug resistance market is segmented into immunodiagnostics, polymerase chain reaction (PCR), next generation sequencing (NGS), Sanger sequencing, and other technologies. In 2018, the immunodiagnostics segment held largest share of the market. The same segment is expected to register the highest CAGR during the forecast period.
End User-Based Insights
In terms of end user, the global antiviral drug resistance market is segmented into hospitals and clinics, pathology or diagnostic laboratories and research institutes. The hospitals and clinics segment held the largest share of the market in 2018, and the same segment is estimated to grow at the fastest rate during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Antiviral Drug Resistance Market: Strategic Insights
Market Size Value in US$ 2,572.26 Million in 2018 Market Size Value by US$ 4,573.24 Million by 2027 Growth rate CAGR of 6.8% from 2019-2027 Forecast Period 2019-2027 Base Year 2019
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Antiviral Drug Resistance Market: Strategic Insights
| Market Size Value in | US$ 2,572.26 Million in 2018 |
| Market Size Value by | US$ 4,573.24 Million by 2027 |
| Growth rate | CAGR of 6.8% from 2019-2027 |
| Forecast Period | 2019-2027 |
| Base Year | 2019 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
The global antiviral drug resistance market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.
Global Antiviral Drug Resistance Market – by Product
- Kits and Reagents
- Instruments
Global Antiviral Drug Resistance Market – by Disease Indication
- Human Immunodeficiency Virus (HIV)
- Hepatitis
- Hepatitis B
- Hepatitis C
- Other Hepatitis
- Cytomegalovirus (CMV)
Global Antiviral Drug Resistance Market – by Technology
- Immunodiagnostics
- Polymerase Chain Reaction (PCR)
- Next Generation Sequencing (NGS)
- Sanger Sequencing
- Other Technologies
Global Antiviral Drug Resistance Market – by End- User
- Hospitals & Clinics
- Pathology or Diagnostic Laboratories
- Research Institutes
Global Antiviral Drug Resistance Market – by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
South America and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- AccuBioTech Co., Ltd.
- ACON Laboratories, Inc.
- Siemens AG
- BioMérieux SA
- Bio-Rad Laboratories, Inc.
- Danaher
- Abbott
- BD
- F. Hoffmann-La Roche Ltd.
- Trinity Biotech
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product , Disease Indication , Technology , End User , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Antiviral Drug Resistance Market – By Product
1.3.2 Global Antiviral Drug Resistance Market – By Disease Indication
1.3.3 Global Antiviral Drug Resistance Market – By Technology
1.3.4 Global Antiviral Drug Resistance Market – By End User
1.3.5 Global Antiviral Drug Resistance Market – By Geography
2. Global Antiviral Drug Resistance Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Antiviral Drug Resistance Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
4.3 Expert Opinion
4.4 Cost of Test, By Test Type
4.5 Test Volume, By Region
5. Global Antiviral Drug Resistance Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Rise in the Incidences of Hepatitis Diseases
5.1.2 Increasing Prevalence of HIV/AIDS
5.2 Key Market Restraints
5.2.1 Alternative Approaches
5.3 Key Market Opportunities
5.3.1 Increasing Healthcare Expenditures in Emerging Markets
5.4 Future Trends
5.4.1 Demand For Higher Quality Products
5.5 Impact Analysis
6. Antiviral Drug Resistance Market – Global Analysis
6.1 Global Antiviral Drug Resistance Market Revenue Forecasts And Analysis
6.2 Global Antiviral Drug Resistance Market, By Geography - Forecasts And Analysis
6.3 Positioning of Key Players
7. Global Antiviral Drug Resistance Market Analysis– by Product
7.1 Overview
7.2 Global Antiviral Drug Resistance Market Share by Product 2018 & 2027 (%)
7.3 Kits and Reagents
7.3.1 Overview
7.3.2 Kits and Reagents Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments Market Revenue and Forecast to 2027 (US$ Mn)
8. Global Antiviral Drug Resistance Market Analysis– by Disease Indication
8.1 Overview
8.2 Global Antiviral Drug Resistance Market Share by Disease Indication 2018 & 2027 (%)
8.3 HIV
8.3.1 Overview
8.3.2 HIV Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Hepatitis
8.4.1 Overview
8.4.2 Hepatitis Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Cytomegalovirus (CMV)
8.5.1 Overview
8.5.2 Cytomegalovirus (CMV) Market Revenue and Forecast to 2027 (US$ Mn)
9. Global Antiviral Drug Resistance Market Analysis– by Technology
9.1 Overview
9.2 Global Antiviral Drug Resistance Market Share by Technology 2018 & 2027 (%)
9.3 Immunodiagnostics
9.3.1 Overview
9.3.2 Immunodiagnostics Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Polymerase Chain Reaction (PCR)
9.4.1 Overview
9.4.2 Polymerase Chain Reaction (PCR) Market Revenue and Forecast to 2027 (US$ Mn)
9.5 Next Generation Sequencing (NGS)
9.5.1 Overview
9.5.2 Next Generation Sequencing (NGS) Market Revenue and Forecast to 2027 (US$ Mn)
9.6 Other Technologies
9.6.1 Overview
9.6.2 Other Technologies Market Revenue and Forecast to 2027 (US$ Mn)
10. Global Antiviral Drug Resistance Market Analysis– by End User
10.1 Overview
10.2 Global Antiviral Drug Resistance Market Share by End User 2018 & 2027 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals And Clinics Market Revenue and Forecast to 2027 (US$ Mn)
10.4 Pathology and Diagnostic Laboratories
10.4.1 Overview
10.4.2 Pathology and Diagnostic Laboratories Market Revenue and Forecast to 2027 (US$ Mn)
10.4.3 List of Laboratories, By Region
10.5 Research Institutes
10.5.1 Overview
10.5.2 Research Institutes Market Revenue and Forecast to 2027 (US$ Mn)
11. Antiviral Drug Resistance Market Revenue and Forecasts to 2027 – Geographical Analysis
11.1 North America Antiviral Drug Resistance Market Revenue And Forecasts To 2027
11.1.1 North America Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.2 North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.1.3 North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.1.4 North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.1.5 North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.1.6 North America Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
11.1.7 US Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.7.1 US Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.7.2 US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.1.7.3 US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.1.7.4 US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.1.7.5 US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.1.8 Canada Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.8.1 Canada Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.8.2 Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.1.8.3 Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.1.8.4 Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.1.8.5 Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.1.9 Mexico Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.9.1 Mexico Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.9.2 Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.1.9.3 Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.1.9.4 Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.1.9.5 Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2 Europe Antiviral Drug Resistance Market Revenue And Forecasts To 2027
11.2.1 Europe Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.2 Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.3 Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.4 Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.5 Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.6 Europe Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
11.2.7 UK Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.7.1 UK Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.7.2 UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.7.3 UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.7.4 UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.7.5 UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.8 Germany Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.8.1 Germany Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.8.2 Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.8.3 Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.8.4 Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.8.5 Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.9 France Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.9.1 France Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.9.2 France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.9.3 France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.9.4 France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.9.5 France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.10 Italy Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.10.1 Italy Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.10.2 Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.10.3 Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.10.4 Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.10.5 Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.11 Spain Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.11.1 Spain Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.11.2 Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.11.3 Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.11.4 Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.11.5 Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3 Asia Pacific Antiviral Drug Resistance Market Revenue and Forecasts to 2027
11.3.1 Asia Pacific Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.2 Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.3.3 Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.3.4 Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.3.5 Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3.6 Asia Pacific Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
11.3.7 Japan Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.7.1 Japan Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.7.2 Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.3.7.3 Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.3.7.4 Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.3.7.5 Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3.8 China Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.8.1 China Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.8.2 China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.3.8.3 China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.3.8.4 China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.3.8.5 China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3.9 India Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.9.1 India Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.9.2 India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.3.9.3 India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.3.9.4 India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.3.9.5 India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3.10 South Korea Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.10.1 South Korea Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.10.2 South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.3.10.3 South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.3.10.4 South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.3.10.5 South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3.11 Australia Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.11.1 Australia Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.11.2 Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.3.11.3 Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.3.11.4 Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.3.11.5 Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.4 Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts To 2027
11.4.1 Middle East & Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.2 Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.4.3 Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.4.4 Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.4.5 Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.4.6 Middle East & Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
11.4.7 UAE Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.7.1 UAE Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.7.2 UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.4.7.3 UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.4.7.4 UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.4.7.5 UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.4.8 Saudi Arabia Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.8.1 Saudi Arabia Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.8.2 Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.4.8.3 Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.4.8.4 Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.4.8.5 Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.4.9 South Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.9.1 South Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.9.2 South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.4.9.3 South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.4.9.4 South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.4.9.5 South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.5 South And Central America Antiviral Drug Resistance Market Revenue And Forecasts To 2027
11.5.1 South and Central America Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.2 South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.5.3 South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.5.4 South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.5.5 South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.5.6 South and Central America Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
11.5.7 Argentina Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.7.1 Argentina Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.7.2 Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.5.7.3 Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.5.7.4 Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.5.7.5 Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.5.8 Brazil Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.8.1 Brazil Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.8.2 Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.5.8.3 Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.5.8.4 Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.5.8.5 Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
12. Antiviral Drug Resistance Market– Industry Landscape
12.1 Overview
13. Antiviral Drug Resistance Market–Key Company Profiles
13.1 AccuBioTech Co., Ltd.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Financial Overview
13.1.4 Product Portfolio
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 ACON Laboratories, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Financial Overview
13.2.4 Product Portfolio
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Siemens AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Financial Overview
13.3.4 Product Portfolio
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 bioMérieux SA
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Financial Information
13.4.4 Product Portfolio
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Bio-Rad Laboratories, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Financial Information
13.5.4 Product Portfolio
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Danaher
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Financial Overview
13.6.4 Product Portfolio
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Abbott
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Financial Overview
13.7.4 Product Portfolio
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 BD
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Financial Overview
13.8.4 Product Portfolio
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 F. Hoffmann-La Roche Ltd.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Financial Overview
13.9.4 Product Portfolio
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Trinity Biotech
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Financial Overview
13.10.4 Product Portfolio
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 2. North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 3. North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 4. North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 5. US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 6. US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 7. US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 8. US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 9. Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 10. Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 11. Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 12. Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 13. Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 14. Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 15. Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 16. Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 17. Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 18. Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 19. Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 20. Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 21. UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 22. UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 23. UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 24. UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 25. Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 26. Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 27. Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 28. Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 29. France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 30. France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 31. France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 32. France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 33. Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 34. Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 35. Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 36. Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 37. Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 38. Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 39. Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 40. Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 41. Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 42. Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 43. Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 44. Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 45. Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 46. Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 47. Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 48. Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 49. China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 50. China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 51. China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 52. China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 53. India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 54. India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 55. India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 56. India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 57. South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 58. South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 59. South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 60. South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 61. Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 62. Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 63. Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 64. Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 65. Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 66. Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 67. Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 68. Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 69. UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 70. UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 71. UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 72. UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 73. Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 74. Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 75. Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 76. Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 77. South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 78. South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 79. South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 80. South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 81. South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 82. South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 83. South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 84. South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 85. Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 86. Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 87. Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 88. Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 89. Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 90. Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 91. Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 92. Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 93. Glossary of Terms, Antiviral Drug Resistance Market
LIST OF FIGURES
Figure 1. Antiviral Drug Resistance Market Segmentation
Figure 2. Antiviral Drug Resistance Segmentation, by Region
Figure 3. Asia Pacific Antiviral Drug Resistance Market, Revenue (US$ Mn), 2018 & 2027
Figure 4. Global Antiviral Drug Resistance Market By Product, Market Share (%), 2018
Figure 5. Global Antiviral Drug Resistance Market By Disease Indication, Market Share (%), 2018
Figure 6. Global Antiviral Drug Resistance Market By Technology, Market Share (%), 2018
Figure 7. Global Antiviral Drug Resistance Market By End User, Market Share (%), 2018
Figure 8. North America : PEST Analysis
Figure 9. Europe: PEST Analysis
Figure 10. Asia - Pacific: PEST Analysis
Figure 11. Middle East & Africa: PEST Analysis
Figure 12. South & Central America: PEST Analysis
Figure 13. Antiviral Drug Resistance Market Impact Analysis of Driver and Restraints
Figure 14. Global Antiviral Drug Resistance Market – Revenue Forecasts and Analysis – 2018- 2027
Figure 15. Global Antiviral Drug Resistance Market – by Geography Forecasts and Analysis – 2018- 2027
Figure 16. Prominent Players in the Antiviral Drug Resistance Market
Figure 17. Global Antiviral Drug Resistance Market Share by Product 2018 & 2027 (%)
Figure 18. Kits and Reagents Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 19. Instruments Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 20. Global Antiviral Drug Resistance Market Share by Disease Indication 2018 & 2027 (%)
Figure 21. HIV Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 22. Hepatitis Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 23. Cytomegalovirus (CMV) Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 24. Global Antiviral Drug Resistance Market Share by Technology 2018 & 2027 (%)
Figure 25. Immunodiagnostics Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 26. Polymerase Chain Reaction (PCR) Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 27. Next Generation Sequencing (NGS) Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 28. Other Technologies Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 29. Global Antiviral Drug Resistance Market Share by End User 2018 & 2027 (%)
Figure 30. Hospitals And Clinics Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 31. Pathology And Diagnostic Laboratories Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 32. RESEARCH INSTITUTES Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 33. North America Antiviral Drug Resistance Market Revenue Overview, by Country, 2018 (US$ Mn)
Figure 34. North America Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 35. North America Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
Figure 36. US Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 37. Canada Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 38. Mexico Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 39. Europe Antiviral Drug Resistance Market Revenue Overview, by Country, 2018 (US$ Mn)
Figure 40. Europe Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 41. Europe Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
Figure 42. UK Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 43. Germany Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 44. France Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 45. Italy Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 46. Spain Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 47. Asia Pacific Antiviral Drug Resistance Market Revenue Overview, by Country, 2018 (US$ Mn)
Figure 48. Asia Pacific Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 49. Asia Pacific Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
Figure 50. Japan Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 51. China Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 52. India Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 53. South Korea Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 54. Australia Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 55. Middle East & Africa Antiviral Drug Resistance Market Revenue Overview, by Country, 2018 (US$ Mn)
Figure 56. Middle East & Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 57. Middle East & Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
Figure 58. UAE Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 59. Saudi Arabia Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 60. South Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 61. South and Central America Antiviral Drug Resistance Market Revenue Overview, by Country, 2018 (US$ Mn)
Figure 62. South and Central America Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 63. South and Central America Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
Figure 64. Argentina Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 65. Brazil Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
The List of Companies - Antiviral Drug Resistance Market
- Danaher
- Abbott
- BD
- F. Hoffmann-La Roche Ltd
- Trinity Biotech
- Seimens AG
- bioMérieux SA
- Bio-Rad Laboratories, Inc
- AccuBioTech Co., Ltd.
- ACON Laboratories, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Antiviral Drug Resistance Market
Aug 2019
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Aug 2019
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2019
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Aug 2019
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Aug 2019
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Aug 2019
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Aug 2019
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Aug 2019